APA (7th ed.) Citation

Wen, D., Li, X., He, Y., Ren, X., & Zheng, C. (2019). Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment. Clinical & Experimental Ophthalmology, 47(5), 686. https://doi.org/10.1111/ceo.13483

Chicago Style (17th ed.) Citation

Wen, Dejia, Xiao‐Rong Li, Ye He, Xinjun Ren, and Chuanzhen Zheng. "Dexamethasone Intravitreous Implant Vs Bevacizumab for Central Retinal Vein Occlusion‐related Macular Oedema: A Prospective Randomized Comparison—Comment." Clinical & Experimental Ophthalmology 47, no. 5 (2019): 686. https://doi.org/10.1111/ceo.13483.

MLA (9th ed.) Citation

Wen, Dejia, et al. "Dexamethasone Intravitreous Implant Vs Bevacizumab for Central Retinal Vein Occlusion‐related Macular Oedema: A Prospective Randomized Comparison—Comment." Clinical & Experimental Ophthalmology, vol. 47, no. 5, 2019, p. 686, https://doi.org/10.1111/ceo.13483.